Zobrazeno 1 - 10
of 40
pro vyhledávání: '"A N, Chremos"'
Autor:
Laurence O. Watkins, Athanassios N. Chremos, Harold W. Schnaper, Alexandra Langendorfer, Michael L Prisant, Reagan H. Bradford, Maria Downton
Publikováno v:
The American Journal of Cardiology. 78:420-424
A paucity of substantive data from clinical drug trials is available specifically evaluating the effects of therapy for hypercholesterolemia in African-Americans, even though a substantial number are candidates for medical advice and intervention for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28555bdb26dbee5d7d63fc14c68cd607
https://doi.org/10.1016/s0002-9149(96)00330-x
https://doi.org/10.1016/s0002-9149(96)00330-x
Autor:
James L. Pool, Carlos A. Dujovne, Harold W. Schnaper, Jim Higgins, Athanassios N. Chremos, Charles L. Shear, Frank A. Franklin, Alexandra Langendorfer, David T. Nash, Ruth B. Grillo, Reagan H. Bradford
Publikováno v:
The American Journal of Cardiology. 74:667-673
The Expanded Clinical Evaluation of Lovastatin study, a randomized, double-blind, placebo- and diet-controlled multicenter trial, evaluated the efficacy and tolerability of lovastatin over 48 weeks in 8,245 patients with moderately severe hypercholes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73581d8010efe199254d608122c2838
https://doi.org/10.1016/0002-9149(94)90307-7
https://doi.org/10.1016/0002-9149(94)90307-7
Autor:
Frank A. Franklin, Charles L. Shear, Dennis P. Hurley, Harold W. Schnaper, Alexandra Langendorfer, Michael Hesney, Carlos A. Dujovne, Reagan H. Bradford, David T. Nash, James L. Pool, Athanassios N. Chremos
Publikováno v:
The American Journal of Medicine. 91:S18-S24
In the multicenter, double-blind EXCEL (Expanded Clinical Evaluation of Lovastatin) study the efficacy of lovastatin in modifying plasma lipids and lipoproteins in 8,245 participants with moderate primary hypercholesterolemia was evaluated. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54a75d9177caf6063e6238ced2b5240
https://doi.org/10.1016/0002-9343(91)90052-y
https://doi.org/10.1016/0002-9343(91)90052-y
Autor:
Frank A. Franklin, Harold W. Schnaper, Alexandra Langendorfer, Dennis P. Hurley, Carlos A. Dujovne, Jim Higgins, Athanassios N. Chremos, James L. Pool, David T. Nash, Maria Downton, A. Lawrence Gould, Michael Hesney, Charles L. Shear, Reagan H. Bradford
Publikováno v:
Archives of Internal Medicine. 151:43-49
In the Expanded Clinical Evaluation of Lovastatin (EXCEL) Study, a multicenter, double-blind, diet- and placebo-controlled trial, we evaluated the efficacy and safety of lovastatin in 8245 patients with moderate hypercholesterolemia. Patients were ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b266d0755d3157342a32b5a51a617f3
https://doi.org/10.1001/archinte.151.1.43
https://doi.org/10.1001/archinte.151.1.43
Autor:
James L. Pool, Alexandra Langendorfer, Michael Hesney, Harold W. Schnaper, Charles L. Shear, Carlos A. Dujovne, Wendy P. Stephenson, Jim Higgins, Athanassios N. Chremos, Frank A. Franklin, Reagan H. Bradford
Publikováno v:
The American Journal of Cardiology. 66:B44-B55
The randomized, double-blind, placebo-controlled trial described in this report was undertaken to clarify the dose-response relation of lovastatin therapy to lipid-modifying efficacy (lipid/lipoprotein modification) and drug-related adverse events in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9820ade2c59b463d23f2534362d0d787
https://doi.org/10.1016/0002-9149(90)90440-c
https://doi.org/10.1016/0002-9149(90)90440-c
Autor:
L M, Prisant, M, Downton, L O, Watkins, H, Schnaper, R H, Bradford, A N, Chremos, A, Langendörfer
Publikováno v:
The American journal of cardiology. 78(4)
A paucity of substantive data from clinical drug trials is available specifically evaluating the effects of therapy for hypercholesterolemia in African-Americans, even though a substantial number are candidates for medical advice and intervention for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec21f5f04032f7b287593b2302347fdb
https://pubmed.ncbi.nlm.nih.gov/8752186
https://pubmed.ncbi.nlm.nih.gov/8752186
Autor:
Dennis P. Hurley, Sandra S. Stinnett, Reagan H. Bradford, Frank A. Franklin, Athanassios N. Chremos, Alexandra Langendorfer, David T. Nash, Charles L. Shear
Publikováno v:
Circulation. 85(4)
BACKGROUND Lovastatin produces consistent dose-related reductions in plasma levels of low density lipoprotein (LDL) cholesterol along with variable decreases in triglycerides and increases in high density lipoprotein (HDL) cholesterol. Patient charac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86433b39b6886a72279075f1b0e5ef46
https://pubmed.ncbi.nlm.nih.gov/1555273
https://pubmed.ncbi.nlm.nih.gov/1555273
Autor:
James L. Pool, Sandra S. Stinnett, C Dujovne, A N Chremos, C L Shear, R H Bradford, H Schnaper, M Downton
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 19(3)
Hypertension and hypercholesterolemia frequently coexist and may require concomitant drug treatments. The efficacy and safety profile of lovastatin given in the presence of antihypertensive medication was evaluated using patient subgroups identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e19ba8ba965493e5d26081272faa6fd
https://pubmed.ncbi.nlm.nih.gov/1347757
https://pubmed.ncbi.nlm.nih.gov/1347757
Autor:
Reagan H. Bradford, Harold W. Schnaper, Charles L. Shear, Maria Downton, Alexandra Langendorfer, James E. Higgins, James L. Pool, Carlos A. Dujovne, Athanassios N. Chremos, A. Lawrence Gould, Frank A. Franklin, David T. Nash
Publikováno v:
The American journal of medicine. 91(1B)
This randomized, double-blind, multicenter, diet-and-placebo-controlled study was designed to clarify the dose-response relationship of lovastatin therapy to lipid-modifying efficacy and drug-related adverse events. Exclusion criteria were minimized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad51283a4c81352a95bcbd25a9480ef7
https://pubmed.ncbi.nlm.nih.gov/1831006
https://pubmed.ncbi.nlm.nih.gov/1831006
Autor:
Dennis P. Hurley, Wendy P. Stephenson, Erik A. Lippa, Hugh R. Taylor, Mary Ann Tupy-Visich, Charles L. Shear, Alan M. Laties, Edwin U. Keates, A. Lawrence Gould, Athanassios N. Chremos
Publikováno v:
The American journal of cardiology. 67(6)
The crystalline lenses of hypercholesterolemic patients were assessed before and after 48 weeks of treatment with lovastatin or placebo to determine the effect of lovastatin on the human lens. Patients were given a biomicroscopic (slit-lamp) examinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a435b247f9e8d8c9b63ccfe803551bf1
https://pubmed.ncbi.nlm.nih.gov/1998274
https://pubmed.ncbi.nlm.nih.gov/1998274